-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Maintains Buy on CVS Health, Raises Price Target to $114

Benzinga·08/19/2026 13:25:35
語音播報
Argus Research analyst Steve Silver maintains CVS Health (NYSE:CVS) with a Buy and raises the price target from $104 to $114.